Hope Rugo, M.D., University Of California San Francisco discusses IMpassion130, Solar-1 Trial Data. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
Related Posts
Hope for Gliomas: The Ruxolitinib Breakthrough
Brain
11 Mins Read
Vorasidenib: Insights from the INDIGO Trial
Brain
11 Mins Read